The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,387,456 in first-year total cost, median $552,152.
Most frequent study sections
- Special Emphasis Panel[ZAI1 CB-A (M1)]4
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
- UNIVERSITY OF PENNSYLVANIA1
- UNIVERSITY OF TORONTO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Epigenetic HIV Silencing in Macrophages1R61AI133696-01 | COLLMAN, RONALD GLIEBERMAN, PAUL M. | UNIVERSITY OF PENNSYLVANIA, PA | $886,903 | ZAI1 |
| 2017 | Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection1R61AI133679-01 | KUTSCH, OLAF | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $654,010 | ZAI1 |
| 2017 | Harnessing the PIWI piRNA pathway to silence HIV1R61DA045622-01 | OSTROWSKI, MARIO | UNIVERSITY OF TORONTO, ON | $450,293 | ZAI1 |
| 2017 | Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation1R61AI133697-01 | FENG, QIN | BAYLOR COLLEGE OF MEDICINE, TX | $396,250 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.